Steris Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by STERIS Plc on February 3, 2021, reporting events that occurred on January 29, 2021. The filing details significant changes to the Company's executive leadership and Board of Directors, including the announced retirement of the current CEO and the appointment of a successor.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
- CEO Transition: Walter M. Rosebrough announced his intention to retire as President and CEO effective July 29, 2021, following the 2021 Annual General Meeting. He has served in this role since 2007.
- Succession Plan: Daniel A. Carestio, currently Senior Vice President and Chief Operating Officer, was elected to succeed Mr. Rosebrough as President and CEO, effective immediately following the Annual General Meeting.
- Board Expansion: The Board of Directors increased its size from nine to ten members, electing Mr. Carestio as a Director effective immediately.
Compensation and Management Commentary
Walter M. Rosebrough (Outgoing CEO):
- Executed a Transition Agreement effective July 31, 2021, for a two-year period ending July 31, 2023.
- Will serve as CEO Emeritus and Senior Advisor on a part-time basis (approx. five days per month).
- Compensation includes a reduced salary of $250,000 per year and a bonus target of 120% of salary under the Management and Incentive Compensation Plan (MICP).
- Reimbursement for COBRA medical and dental expenses through the end of 2021.
- No severance plan benefits are payable unless terminated without Cause.
Daniel A. Carestio (Incoming CEO):
- Base salary will increase to an annual rate of $875,000 upon assuming the CEO role.
- Target bonus opportunity under the MICP will increase to 110% of base salary.
- Will receive an equity award (restricted stock and stock options) valued at approximately $3.3 million at the time of the June 2021 annual equity awards.
Investor Verification Checklist
- Verify the exact date of the 2021 Annual General Meeting to confirm the effective date of the CEO transition.
- Review the full text of the Transition Agreement (Exhibit 10) to understand specific definitions of "Cause" and termination conditions.
- Confirm the valuation methodology for the $3.3 million equity award granted to Mr. Carestio.
- Monitor future filings for any updates to the Board composition or additional executive appointments.